Out of control: Hepatitis B reactivation by transarterial treatment of hepatocellular carcinoma

Journal of Hepatology

Volumn 41, Issue 3, 2004, Pages 482-484

  Von Weizsäcker, Fritz ^a   Blum, Hubert E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; CISPLATIN; EPIRUBICIN; IODINATED POPPYSEED OIL; LAMIVUDINE; NUCLEOTIDE;

ARTIFICIAL EMBOLISM; CANCER RISK; CHEMOTHERAPY; COMPARATIVE STUDY; DISEASE DURATION; DISEASE TRANSMISSION; EDITORIAL; GENDER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER INJURY; LIVER TRANSPLANTATION; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURGICAL TECHNIQUE; SURVIVAL; VACCINATION; VIRUS REPLICATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; VIRUS ACTIVATION;

EID: 4344611916     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.07.005     Document Type: Editorial

References (20)

1. WHO World Health Report 1996: fighting disease, fostering development 1996 World Health Organization Geneva
2. C.L. Lai, V. Ratziu, M.F. Yuen, and T. Poynard Viral hepatitis B Lancet 362 2003 2089 2094
3. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
4. J. Bruix, L. Boix, M. Sala, and J.M. Llovet Focus on hepatocellular carcinoma Cancer Cell 5 2004 215 219
5. Y. Yano, F. Yamashita, S. Sumie, E. Ando, K. Fukumori, and M. Kiyama Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan Am J Gastroenterol 97 2002 156 161
6. T. Pollicino, G. Squadrito, G. Cerenzia, I. Cacciola, G. Raffa, and A. Crax Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection Gastroenterology 126 2004 102 110
7. F.L. Clark, M.W. Drummond, S. Chambers, B.A. Chapman, and W.N. Patton Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high grade non Hodgkin's lymphoma see comments Ann Oncol 9 1998 385 387
8. F. ter Borg, S. Smorenburg, R.A. de Man, R.C. Rietbroek, R.A. Chamuleau, and E.A. Jones Recovery from life threatening, corticosteroid unresponsive, chemotherapy related reactivation of hepatitis B associated with lamivudine therapy Dig Dis Sci 43 1998 2267 2270
9. A. Ahmed, and E.B. Keeffe Lamivudine therapy for chemotherapy induced reactivation of hepatitis B virus infection Am J Gastroenterol 94 1999 249 251
10. O.H. Al-Taie, H. Mork, A.M. Gassel, M. Wilhelm, B. Weissbrich, and M. Scheurlen Prevention of hepatitis B flare up during chemotherapy using lamivudine: case report and review of the literature Ann Hematol 78 1999 247 249
11. W. Yeo, J.L. Steinberg, J.S. Tam, P.K. Chan, N.W. Leung, and K.C. Lam Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy in process citation J Med Virol 59 1999 263 269
12. J.H. Hoofnagle, G.M. Dusheiko, D.F. Schafer, E.A. Jones, K.C. Micetich, and R.C. Young Reactivation of chronic hepatitis B virus infection by cancer chemotherapy Ann Intern Med 96 1982 447 449
13. W. Yeo, P.K. Chan, S. Zhong, W.M. Ho, J.L. Steinberg, and J.S. Tam Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors J Med Virol 62 2000 299 307
14. A. Tamori, S. Nishiguchi, M. Tanaka, H. Kurooka, S. Fujimoto, and K. Nakamura Lamivudine therapy for hepatitis B virus reactivation in a patient receiving intra-arterial chemotherapy for advanced hepatocellular carcinoma Hepatol Res 26 2003 77 80
15. G.B. Vizzini, A. Luca, and I.R. Marino Hepatitis B virus reactivation after a single session of transarterial chemoembolization in patients with hepatocellular carcinoma Ann Intern Med 138 2003 691 692
16. W.J. Jang, J.Y. Choi, S.H. Bae, C.W. Kim, S.K. Yoon, and S.H. Cho Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma J Hepatol 41 2004 427 435
17. J. Bruix, and J.M Llovet Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 2002 519 524
18. J.H. Kao, and D.S. Chen Global control of hepatitis B virus infection Lancet Infect Dis 2 2002 395 403
19. A. Tsubota, Y. Arase, F. Ren, H. Tanaka, K. Ikeda, and H. Kumada Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw J Med Virol 65 2001 257 265
20. L.G. Guidotti, B. Matzke, and F.V. Chisari Hepatitis B virus replication is cell cycle independent during liver regeneration in transgenic mice J Virol 71 1997 4804 4808